Guideline Detail

Use of fixed-dose combinations in place of lamivudine single agents

Source: South Africa National Department of Health
Publication Date: January 7, 2016

View Guideline

Circular advising of new policy to change persons on single-tablet lamivudine to combination agents whenever possible. It asks that clinicians reserve the use of the 150mg lamivudine tablets, which will continue to be available, for complicated and paediatric cases.

Browse All Guidelines